We are live on ! Find out more
EDSA icon

Edesa Biotech
EDSA

11 hedge funds and large institutions have $97K invested in Edesa Biotech in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more capital invested

Capital invested by funds: $58K → $97K (+$39K)

50% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 2

10% more funds holding

Funds holding: 10 → 11 (+1)

0.01% more ownership

Funds ownership: 0.03% → 0.04% (+0.01%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
11
Holders Change
+1
Holders Change %
+10%
% of All Funds
0.24%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$18.7K
2
TSS
Two Sigma Securities
New York
+$13.1K
3
Renaissance Technologies
Renaissance Technologies
New York
+$11.1K
4
AWM
AllSquare Wealth Management
New York
+$99

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$12.7K
2
AG
Advisor Group
Arizona
-$296

EDSA Hedge Fund Activity: Q1 2019 in Review

11 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q1 2019, worth a combined $97K — up 67% from $58K a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new EDSA positions and 2 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Virtu Financial, opening a new position worth an estimated $18.7K. The largest seller was UBS Group, cutting an estimated $12.7K.

  • 11 institutional investors held Edesa Biotech (EDSA) as of Q1 2019, up from 10 in Q4 2018.
  • Funds reported $97K of Edesa Biotech stock for Q1 2019, up 67% quarter-over-quarter.
  • 3 funds opened new Edesa Biotech positions in Q1 2019 and 2 closed out, a net change of +1 holder.
  • The largest Edesa Biotech buyer in Q1 2019 was Virtu Financial, an estimated $18.7K added.
  • The largest Edesa Biotech seller in Q1 2019 was UBS Group, an estimated $12.7K sold.

Based on aggregated 13F filings for Q1 2019.